These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2236731)

  • 1. The effect of calcium channel blockers on the cyclosporine dose requirement in renal transplant recipients.
    Howard RL; Shapiro JI; Babcock S; Chan L
    Ren Fail; 1990; 12(2):89-92. PubMed ID: 2236731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression.
    Weir MR
    Am J Med; 1991 May; 90(5A):32S-36S. PubMed ID: 2039018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of calcium-channel blockers on cyclosporine clearance and use in renal transplant patients.
    Sketris IS; Methot ME; Nicol D; Belitsky P; Knox MG
    Ann Pharmacother; 1994 Nov; 28(11):1227-31. PubMed ID: 7849332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cyclosporine blood concentrations due to verapamil administration.
    Maggio TG; Bartels DW
    Drug Intell Clin Pharm; 1988 Sep; 22(9):705-7. PubMed ID: 3063481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction of the calcium channel blockers verapamil and nifedipine with cyclosporin A in pediatric renal transplant patients.
    Crocker JF; Renton KW; LeVatte TL; McLellan DH
    Pediatr Nephrol; 1994 Aug; 8(4):408-11. PubMed ID: 7947026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of calcium channel blockers on cyclosporine and its metabolites in renal transplant recipients.
    Tortorice KL; Heim-Duthoy KL; Awni WM; Rao KV; Kasiske BL
    Ther Drug Monit; 1990 Jul; 12(4):321-8. PubMed ID: 2396304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia.
    Bökenkamp A; Bohnhorst B; Beier C; Albers N; Offner G; Brodehl J
    Pediatr Nephrol; 1994 Apr; 8(2):181-5. PubMed ID: 8018496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nifedipine on renal allograft function and survival beyond one year.
    Shin GT; Cheigh JS; Riggio RR; Suthanthiran M; Stubenbord WT; Serur D; Wang JC; Rubin AL; Stenzel KH
    Clin Nephrol; 1997 Jan; 47(1):33-6. PubMed ID: 9021239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial hypertension in heart transplant recipients treated with triple-drug immunosuppressive therapy.
    Olivari MT; Antolick A; Ring WS
    J Heart Transplant; 1989; 8(1):34-9. PubMed ID: 2647929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.
    Gould BA; Hornung RS; Mann S; Balasubramanian V; Raftery EB
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S369-73. PubMed ID: 6184570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP4A/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats.
    Hammoud SH; Omar AG; Eid AA; El-Mas MM
    Toxicol Appl Pharmacol; 2017 Nov; 334():110-119. PubMed ID: 28899749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of calcium channel blockers as ventricular unloading agents.
    Guazzi MD; Cipolla C; Sganzerla P; Agostoni PG; Fabbiocchi F; Pepi M
    Eur Heart J; 1983 Jan; 4 Suppl A():181-7. PubMed ID: 6220895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine, verapamil and cyclosporin A pharmacokinetics in children.
    Ogborn MR; Crocker JF; Grimm PC
    Pediatr Nephrol; 1989 Jul; 3(3):314-6. PubMed ID: 2702114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of cytomegalovirus disease in renal transplant patients treated with prednisone, azathioprine and cyclosporine using intensive monitoring and decreased immunosuppression.
    Gómez E; de Oña M; Mélon S; Alvarez R; Laures A; Rodríguez M; Pobes A; Alvarez-Grande J
    Nephron; 1999; 82(3):238-45. PubMed ID: 10395996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression.
    Chapman JR; Marcen R; Arias M; Raine AE; Dunnill MS; Morris PJ
    Transplantation; 1987 Jun; 43(6):860-4. PubMed ID: 3296353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.